One example is the CD44v8-10-to-standard CD44-ratio (total ratio of all CD44 alternative splicing isoforms) in urothelial cancer that has been shown to be closely associated with tumor progression and aggressiveness [4,30]. This evidence concerns the gene CD44 and neoplasm.